My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 331

    1.

    Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3 -482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in chinese type 2 diabetic patients.

    Baum L, Ng MC, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpaintner K, Chan JC.

    Diabetes Care. 2005 Jul;28(7):1704-9.PMID: 15983323 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy.

    Ng MC, Baum L, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpaintner K, Chan JC.

    Clin Genet. 2006 Jul;70(1):20-8.PMID: 16813599 [PubMed - indexed for MEDLINE]Related articles

    3.

    The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese.

    Ko YL, Hsu LA, Hsu KH, Ko YH, Lee YS.

    Atherosclerosis. 2004 Jan;172(1):135-42.PMID: 14709367 [PubMed - indexed for MEDLINE]Related articles

    4.

    Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.

    Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K.

    Am J Kidney Dis. 2002 Aug;40(2):243-51.PMID: 12148096 [PubMed - indexed for MEDLINE]Related articles

    5.

    Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster.

    Waterworth DM, Hubacek JA, Pitha J, Kovar J, Poledne R, Humphries SE, Talmud PJ.

    J Lipid Res. 2000 Jul;41(7):1103-9.PMID: 10884292 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II).

    Jansen H, Waterworth DM, Nicaud V, Ehnholm C, Talmud PJ; EARS-II Study Group.

    Ann Hum Genet. 2001 May;65(Pt 3):237-43.PMID: 11427182 [PubMed - indexed for MEDLINE]Related articles

    7.

    Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.

    Liu L, Xiang K, Zheng T, Zhang R, Li M, Li J.

    Mol Cell Biochem. 2003 Dec;254(1-2):353-8.PMID: 14674716 [PubMed - indexed for MEDLINE]Related articles

    8.

    Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians.

    Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, Bhansali A, Khullar M.

    Mol Cell Biochem. 2008 Jul;314(1-2):9-17. Epub 2008 Apr 10.PMID: 18401556 [PubMed - indexed for MEDLINE]Related articles

    9.

    Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.

    Fiegenbaum M, de Andrade FM, Hutz MH.

    Clin Chim Acta. 2007 May 1;380(1-2):175-81. Epub 2007 Feb 15.PMID: 17367769 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.

    Somekawa Y, Umeki H, Kobayashi K, Tomura S, Aso T, Hamaguchi H.

    J Clin Endocrinol Metab. 2002 Oct;87(10):4766-70.PMID: 12364471 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.

    Guan J, Zhao HL, Baum L, Sui Y, He L, Wong H, Lai FM, Tong PC, Chan JC.

    Nephrol Dial Transplant. 2009 Jun;24(6):1889-95. Epub 2009 Feb 14.PMID: 19218599 [PubMed - indexed for MEDLINE]Related articles

    12.

    Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.

    Kwon MK, Rhee SY, Chon S, Oh S, Woo JT, Kim SW, Kim JW, Kim YS, Jeong KH, Lee SH, Lee TW, Ihm CG.

    Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S228-32. Epub 2007 Jul 12.PMID: 17624465 [PubMed - indexed for MEDLINE]Related articles

    13.

    The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.

    Erdogan M, Eroglu Z, Biray C, Karadeniz M, Cetinkalp S, Kosova B, Gunduz C, Topcuoglu N, Ozgen G, Yilmaz C.

    J Endocrinol Invest. 2009 Mar;32(3):219-22.PMID: 19542737 [PubMed - indexed for MEDLINE]Related articles

    14.

    The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

    Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

    Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.PMID: 17689519 [PubMed - indexed for MEDLINE]Related articles

    15.

    Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.

    Sun J, Xu Y, Zhu Y, Lu H.

    Diabetes Res Clin Pract. 2004 Jun;64(3):185-90.PMID: 15126006 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.

    Wang Y, Ng MC, So WY, Ma R, Ko GT, Tong PC, Chan JC.

    Nephrol Dial Transplant. 2005 Dec;20(12):2733-8. Epub 2005 Sep 2.PMID: 16141456 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency.

    Marçais C, Bernard S, Merlin M, Ulhmann M, Mestre B, Rochet-Mingret L, Revol A, Berthezene F, Moulin P.

    Diabetologia. 2000 Nov;43(11):1346-52.PMID: 11126401 [PubMed - indexed for MEDLINE]Related articles

    18.

    Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.

    Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC.

    Diabetes Care. 2003 Aug;26(8):2410-5.PMID: 12882871 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.

    St-Pierre J, Miller-Felix I, Paradis ME, Bergeron J, Lamarche B, Després JP, Gaudet D, Vohl MC.

    Mol Genet Metab. 2003 Jan;78(1):31-6.PMID: 12559845 [PubMed - indexed for MEDLINE]Related articles

    20.

    Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population.

    Fang DZ, Liu BW.

    Atherosclerosis. 2002 Apr;161(2):417-24.PMID: 11888526 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity